ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,135Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 151

$405K Total Retail Price of All Prescriptions

Rank: 68 out of 151

492 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 10,027 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 774 692 1 5
SIMVASTATIN 628 535 2 1
METOPROLOL TARTRATE 388 379 3 7
OMEPRAZOLE 362 311 4 4
FUROSEMIDE 349 312 5 6
LOVASTATIN 310 302 6 31
METFORMIN HCL 294 258 7 8
AMLODIPINE BESYLATE 292 263 8 3
LEVOTHYROXINE SODIUM 284 265 9 2
WARFARIN SODIUM 263 249 10 9
ATENOLOL 248 223 11 11
GABAPENTIN 214 199 12 14
ZOLPIDEM TARTRATE 200 188 13 17
LOSARTAN POTASSIUM 197 191 14 12
TRAMADOL HCL 159 142 15 24
GLIPIZIDE 151 113 16 43
POTASSIUM CHLORIDE 145 145 17 19
HYDROCHLOROTHIAZIDE 142 125 18 13
ALLOPURINOL 139 128 19 42
CARVEDILOL 129 119 20 22
DIGOXIN 128 118 21 39
HYDROCODONE-ACETAMINOPHEN 113 101 S3 22 10
CITALOPRAM HBR 105 89 23 18
PREDNISONE 97 85 24 45
CLONIDINE HCL 96 83 25 52
CIPROFLOXACIN HCL 96 83 25 51
TAMSULOSIN HCL 93 83 27 30
GLIMEPIRIDE 90 79 28 58
AZITHROMYCIN 89 75 29 36
ALENDRONATE SODIUM 89 82 29 26
PAROXETINE HCL 88 78 31 54
GLYBURIDE 82 76 R 32 75
CLOPIDOGREL 79 63 33 29
DOXAZOSIN MESYLATE 77 77 34 77
SPIRONOLACTONE 74 58 35 72
AMITRIPTYLINE HCL 71 55 R 36 156
BUMETANIDE 67 64 37 158
ISOSORBIDE MONONITRATE ER 67 67 37 55
BUSPIRONE HCL 66 50 39 127
PLAVIX 64 57 40 37
NAMENDA 60 48 41 20
PRAVASTATIN SODIUM 59 55 42 23
DONEPEZIL HCL 57 41 43 15
ADVAIR DISKUS 54 54 44 46
OXYBUTYNIN CHLORIDE 52 47 45 117
LANTUS SOLOSTAR 51 44 46 133
NIFEDIPINE ER 50 50 47 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.